Modulation of hemostatic mechanisms in bacterial infectious diseases

Slides:

Advertisements

Similar presentations

Disseminated Intravascular Coagulation

Advertisements

 An acquired syndrome characterized by systemic intravascular coagulation  Coagulation is always the initial event.  Most morbidity and mortality depends.

CHAPTER13 Biomaterials and Thrombosis 13-1 Introduction: Overview of Hemostasis Blood-Biomaterials Interaction via protein coats ---- blood coagulation.

Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.

HEMOSTAZ Yard. Doç. Dr. Murat ÖRMEN. Vessels Platelets Fibrinolysis/Inhibitors Coagulation Proteins BleedingClotting Hemostaz.

HEMOSTASIS. Hemostasis a body mechanism to stop traumatic bleeding to prevent spontaneous bleeding to keep the fluidity of blood.

Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.

Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.

Drmsaiem FIBRINOLSIS SYSTEM DR MOHAMMED SAIEMALDAHR Faculty of Applied Medical Sciences Medical Technology Dep.

Section 10: Nutrients and their functions Vitamin K and blood clot formation 01/27/06.

Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.

Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.

DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.

Disseminated Intravascular Coagulation (DIC) 【 Change of basic pathology 】【 Change of basic pathology 】 Key change Key change This fine homeostatic.

Coagulation Mechanisms

HAEMOSTASIS & FIBRINOLYSIS

PHYSIOLOGIC CONTROL OF HEMOSTASIS MLAB Coagulation Keri Brophy-Martinez.

MLAB Coagulation Keri Brophy-Martinez Fibrinolytic System.

Coagulation and fibrinolysis

Hemodynamics 2.

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.

Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.

Revised model of coagulation

Principles of Blood Coagulation

More detailed view of the process shown in Fig

HAEMOSTASIS AND THROMBOSIS Regulation of coagulation

Anesthes. 2010;113(5): doi: /ALN.0b013e3181f22b5a Figure Legend:

FIBRINOLSIS SYSTEM Ahmad Shihada Silmi Msc, FIBMS IUG

Regulation of blood coagulation

by Bernhard Nieswandt, and Johan W. M. Heemskerk

Nat. Rev. Nephrol. doi: /nrneph

Disruption of Protein-Membrane Binding and Identification of Small-Molecule Inhibitors of Coagulation Factor VIII P.Clint Spiegel, Shari M. Kaiser, Julian.

Bruised Black and Blue: Acquired Hypoprothrombinemia

Perioperative management of the bleeding patient

Ahmad Shihada Silmi Msc, FIBMS IUG Medical Lab. sciences Dept

Thanks for the complement (inhibitor)‏

Bruised Black and Blue: Acquired Hypoprothrombinemia

Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm Robert S.M. Davies,

Important port for SHIP-1 at Dok-3

Fusion genes in cord blood

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism by Sabine Eichinger, Verena Schönauer, Ansgar Weltermann,

by Laurent O. Mosnier, Paula Buijtenhuijs, Pauline F. Marx, Joost C. M

Thrombin generation: biochemical possibilities and clinical reality

Coagulation and innate immune responses: can we view them separately?

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies by.

What type of tissue is indicated by the blue arrow?

Figure 1 The coagulation system

Thrombin During Cardiopulmonary Bypass

Figure 4 Cascade system activation on a biomaterial surface

Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels Kusumam Joseph, PhD,

What Color is it?.

Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris

Anders Wanhainen, MD, PhD, Torbjörn K

Anti-Coagulants Physical Process of Clotting

Chapter 15 Arterial and Venous Thrombosis and Thrombolysis

Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris

Volume 73, Issue 10, Pages (May 2008)

Antifibrinolytic therapy: new data and new concepts

Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability by Georgette L. Suidan, Pradeep K. Singh,

A simplified representation of the coagulation cascade.

The alveolar compartment in idiopathic pulmonary fibrosis (IPF).

Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications.

HUS and atypical HUS by T. Sakari Jokiranta Blood

Editorial III British Journal of Anaesthesia

How I treat disseminated intravascular coagulation

Specificity profiling, activity in human plasma, and x-ray structure

Coagulation cascade influenced by renal dysfunction and mechanisms of action of oral anticoagulants. Coagulation cascade influenced by renal dysfunction.

Schematic model of the role of complement activation, cell damage, and thrombosis in various severe diseases or conditions with major thrombotic problems.

Effects of vitamin K antagonists (VKA), such as warfarin, low-molecular-weight heparin (LMWH), and dabigatran, on the coagulation pathway. Effects of vitamin.

Presentation transcript:

Modulation of hemostatic mechanisms in bacterial infectious diseases by Hans Tapper, and Heiko Herwald Blood Volume 96(7):2329-2337 October 1, 2000 ©2000 by American Society of Hematology

The blood coagulation cascade The blood coagulation cascade.The coagulation cascade is divided into an intrinsic and an extrinsic pathway. The blood coagulation cascade.The coagulation cascade is divided into an intrinsic and an extrinsic pathway. Coagulation factors are represented in blue and are designated by an “a” upon activation. Arrows symbolize the proteolytic conversion. Cofactors are marked in red and coagulation inhibitors in green. Proteins that participate in fibrinolysis have a brown color. The following abbreviations are used: F, factor; HK, high molecular weight kininogen; PAI-1, plasminogen activator inhibitor; PK, plasma kallikrein; TAFI, thrombin activatable fibrinolysis inhibitor; TFPI, tissue factor pathway inhibitor; tPA, tissue plasminogen activator; and uPA, urokinase-type plasminogen activator. Strong and weak interactions are indicated by solid and dotted lines. Hans Tapper, and Heiko Herwald Blood 2000;96:2329-2337 ©2000 by American Society of Hematology